Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Axal

Approved

STANDARD

Axal

Amson Vaccines and Pharma (Pvt.) Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 0316fbf0be788b39
Company: Amson Vaccines and Pharma (Pvt.) Ltd.
Type: Standard

Approval Details

Approval Id: 0316fbf0be788b39
Drug Approval Philippines Name: Axal
Product Name: Axal
Registration Number: DR-XY38992
Brand Name: Axal
Generic Name: Alprazolam
Dosage Form: Tablet
Dosage Strength: 250mcg
Manufacturer: Amson Vaccines and Pharma (Pvt.) Ltd.
Importer: Sahar International Trading, Inc.
Distributor: Sahar International Trading, Inc.
Issuance Date: 26 April 2021
Expiry Date: 27 January 2026
Pharmacologic Category: Anxiolytic (Benzodiazepine derivative)
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

0316fbf0be788b39

Type

Standard

Back to Philippines FDA Approvals

Axal - Philippines FDA Drug Approval Details